These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 5032774

  • 21. Clofibrate: a final verdict?
    Lancet; 1978 Nov 25; 2(8100):1131-2. PubMed ID: 82687
    [No Abstract] [Full Text] [Related]

  • 22. Diet and coronary disease.
    McMichael J.
    Acta Med Scand; 1980 Nov 25; 207(3):151-2. PubMed ID: 7368980
    [No Abstract] [Full Text] [Related]

  • 23. Clofibrate and the prevention of ischaemic heart disease.
    N Z Med J; 1979 Jun 13; 89(637):435-6. PubMed ID: 289017
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Hyperlipidaemia advances and retreats.
    Br Med J; 1980 Aug 02; 281(6236):340-1. PubMed ID: 7427268
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Results of a 5-year study of the action of clofibrate in the treatment of ischemic cardiopathy].
    Dewar HA.
    Minerva Med; 1971 Sep 26; 62(72):3456-7. PubMed ID: 5097216
    [No Abstract] [Full Text] [Related]

  • 28. Hyperlipidemia: reducing the chances of cardiovascular disease.
    Nash DT.
    Geriatrics; 1984 Jul 26; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
    [No Abstract] [Full Text] [Related]

  • 29. Prevention of ischaemic heart disease. Possibilities and problems.
    Fejfar Z, Vanĕcek R.
    Rev Czech Med; 1970 Jul 26; 16(4):161-70. PubMed ID: 5491480
    [No Abstract] [Full Text] [Related]

  • 30. [Clofibrate and ischemic heart disease].
    Oye I.
    Tidsskr Nor Laegeforen; 1973 Jan 10; 93(1):33-4. PubMed ID: 4691223
    [No Abstract] [Full Text] [Related]

  • 31. The value of clofibrate.
    Hart A.
    N Z Med J; 1978 Jun 14; 87(613):406. PubMed ID: 277806
    [No Abstract] [Full Text] [Related]

  • 32. [Use of Clofibrate Spofa in the prevention of ischemic heart disease].
    Geizerová H, Grafnetter D, Hejl Z.
    Cas Lek Cesk; 1972 Jun 12; 111(20):466-9. PubMed ID: 5046003
    [No Abstract] [Full Text] [Related]

  • 33. Angina pectoris--II.
    Br Med J; 1971 Mar 06; 1(5748):545-7. PubMed ID: 5547579
    [No Abstract] [Full Text] [Related]

  • 34. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project.
    Coronary Drug Project Research Group.
    N Engl J Med; 1980 Oct 30; 303(18):1038-41. PubMed ID: 6999345
    [Abstract] [Full Text] [Related]

  • 35. [Clofibrate prevention study by WHO. Results and consequences].
    MMW Munch Med Wochenschr; 1979 Jan 12; 121(2):45-6. PubMed ID: 105256
    [No Abstract] [Full Text] [Related]

  • 36. [The effect of unsaturated fatty acids on the incidence of coronary infarction, etc].
    Natvig H.
    Tidsskr Nor Laegeforen; 1967 Jun 01; 87(11):1033-41. PubMed ID: 6047507
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Clofibrate--more harm than good?].
    Huttunen J.
    Duodecim; 1979 Jun 01; 95(3):97-9. PubMed ID: 761565
    [No Abstract] [Full Text] [Related]

  • 40. Clofibrate in the management of hyperlipidaemia.
    Drug Ther Bull; 1982 May 28; 20(11):41-3. PubMed ID: 7140522
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.